Related Experiment Videos
Glucose modulates cell death due to normobaric hyperoxia by maintaining cellular ATP
1Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado, USA.
The American Journal of Physiology
|February 12, 1998
Summary
Glucose depletion, not hyperoxia itself, causes cell death in human lung cells. Supplementing glucose prevents this cell death, indicating its critical role in hyperoxic injury.
Area of Science:
- Cell Biology
- Biochemistry
- Toxicology
Background:
- Hyperoxia (95% O2) can induce cell death in cultured cells.
- The precise mechanisms driving hyperoxic cell death remain under investigation.
- Glucose metabolism is crucial for cellular energy production and survival.
Purpose of the Study:
- To investigate whether glucose depletion is a primary driver of cell death under hyperoxic conditions.
- To determine the role of glucose availability in protecting lung epithelial cells from hyperoxia-induced damage.
Main Methods:
- Cultured human lung epithelial-like cells (A549) were exposed to hyperoxia (95% O2) with varying initial medium volumes to control glucose depletion rates.
- Cells were either supplemented with glucose regularly or received no supplementation.
- Cell death was assessed by measuring lactate dehydrogenase (LDH) release and adenosine triphosphate (ATP) levels.
- Extracellular pH was monitored.
Main Results:
- Hyperoxic cell death, indicated by increased LDH activity, occurred only after glucose depletion in the medium.
- Cells exposed to hyperoxia without glucose supplementation showed rapid ATP loss and significant LDH release.
- Continuous glucose supplementation prevented cell death and LDH release, even with significant fermentation and acidic extracellular pH (pH 6.5).
Conclusions:
- Glucose depletion, rather than hyperoxia alone, is a critical determinant of cell death in A549 cells under hyperoxic conditions.
- Maintaining adequate glucose levels is essential for cell survival during hyperoxia.
- Targeting glucose metabolism could be a therapeutic strategy to mitigate hyperoxic injury.